Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-EGFR antibody-drug conjugates

Anti-EGFR antibody-drug conjugates

US Patent 11759527 · Granted Sep 19, 2023

Estimated economic value: $1,676,173,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies binding to human CD3 at acidic pH2024
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibi2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Anti-c-Met antibody drug conjugates2023
Anti-c-Met antibody drug conjugates2023
Macrocyclic MCL-1 inhibitors and methods of use2020
Anti-B7-H3 antibodies and antibody drug conjugates2020
Anti-B7-H3 antibodies and antibody drug conjugates2020
Anti-B7-H3 antibodies and antibody drug conjugates2020
Anti-EGFR antibodies and antibody drug conjugates2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2018